Differences in incidence and co-occurrence of vaccine and nonvaccine human papillomavirus types in Finnish population before human papillomavirus mass vaccination suggest competitive advantage for HPV33

Marko Merikukka; Marjo Kaasila; Namujju B Proscovia; Johanna Palmroth; Reinhard Kirnbauer; Jorma Paavonen; Heljä-Marja Surcel; Matti Lehtinen; Proscovia Namujju

doi:10.1002/ijc.25675

Differences in incidence and co-occurrence of vaccine and nonvaccine human papillomavirus types in Finnish population before human papillomavirus mass vaccination suggest competitive advantage for HPV33

Marko Merikukka, Marjo Kaasila, Namujju B Proscovia, Johanna Palmroth, Reinhard Kirnbauer, Jorma Paavonen, Heljä-Marja Surcel, Matti Lehtinen, Proscovia Namujju

Research output: Contribution to journal › Article › Scientific › peer-review

35 Citations (Scopus)

Original language	English
Pages (from-to)	1114-1119
Journal	International Journal of Cancer
Volume	128
Issue number	5
DOIs	https://doi.org/10.1002/ijc.25675
Publication status	Published - 2011
Publication type	A1 Journal article-refereed

Keywords

competition
human papillomavirus
incidence rate ratio
population
serology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/ijc.25675

Cite this

Merikukka, M., Kaasila, M., Proscovia, N. B., Palmroth, J., Kirnbauer, R., Paavonen, J., Surcel, H.-M., Lehtinen, M., & Namujju, P. (2011). Differences in incidence and co-occurrence of vaccine and nonvaccine human papillomavirus types in Finnish population before human papillomavirus mass vaccination suggest competitive advantage for HPV33. International Journal of Cancer, 128(5), 1114-1119. https://doi.org/10.1002/ijc.25675

@article{76691af9f4284440a248c5ed6bd23811,

title = "Differences in incidence and co-occurrence of vaccine and nonvaccine human papillomavirus types in Finnish population before human papillomavirus mass vaccination suggest competitive advantage for HPV33",

keywords = "competition, human papillomavirus, incidence rate ratio, population, serology, competition, human papillomavirus, incidence rate ratio, population, serology",

author = "Marko Merikukka and Marjo Kaasila and Proscovia, {Namujju B} and Johanna Palmroth and Reinhard Kirnbauer and Jorma Paavonen and Helj{\"a}-Marja Surcel and Matti Lehtinen and Proscovia Namujju",

year = "2011",

doi = "10.1002/ijc.25675",

language = "English",

volume = "128",

pages = "1114--1119",

journal = "International Journal of Cancer",

issn = "0020-7136",

publisher = "Wiley",

number = "5",

}

Merikukka, M, Kaasila, M, Proscovia, NB, Palmroth, J, Kirnbauer, R, Paavonen, J, Surcel, H-M, Lehtinen, M & Namujju, P 2011, 'Differences in incidence and co-occurrence of vaccine and nonvaccine human papillomavirus types in Finnish population before human papillomavirus mass vaccination suggest competitive advantage for HPV33', International Journal of Cancer, vol. 128, no. 5, pp. 1114-1119. https://doi.org/10.1002/ijc.25675

Differences in incidence and co-occurrence of vaccine and nonvaccine human papillomavirus types in Finnish population before human papillomavirus mass vaccination suggest competitive advantage for HPV33. / Merikukka, Marko; Kaasila, Marjo; Proscovia, Namujju B et al.
In: International Journal of Cancer, Vol. 128, No. 5, 2011, p. 1114-1119.

Research output: Contribution to journal › Article › Scientific › peer-review

TY - JOUR

T1 - Differences in incidence and co-occurrence of vaccine and nonvaccine human papillomavirus types in Finnish population before human papillomavirus mass vaccination suggest competitive advantage for HPV33

AU - Merikukka, Marko

AU - Kaasila, Marjo

AU - Proscovia, Namujju B

AU - Palmroth, Johanna

AU - Kirnbauer, Reinhard

AU - Paavonen, Jorma

AU - Surcel, Heljä-Marja

AU - Lehtinen, Matti

AU - Namujju, Proscovia

PY - 2011

Y1 - 2011

KW - competition

KW - human papillomavirus

KW - incidence rate ratio

KW - population

KW - serology

KW - competition

KW - human papillomavirus

KW - incidence rate ratio

KW - population

KW - serology

U2 - 10.1002/ijc.25675

DO - 10.1002/ijc.25675

M3 - Article

SN - 0020-7136

VL - 128

SP - 1114

EP - 1119

JO - International Journal of Cancer

JF - International Journal of Cancer

IS - 5

ER -